Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Mr Lozano, In conclusion
5
Aug 21, 2010 05:50PM
5
Aug 21, 2010 06:05PM

Notwithstanding the fact that Rule 14a-8 is allowable under proposed Rule 14a-11, and unless Rule 14a-11 is retroactive, I humbly suggest that any decision can only be based on the Rules as they currently stand.

.

.

.

Be well

1
Aug 21, 2010 07:39PM
Share
New Message
Please login to post a reply